Leflunomide-associated progressive multifocal leukoencephalopathy

Arch Neurol. 2008 Nov;65(11):1538-9. doi: 10.1001/archneur.65.11.1538.

Authors

Megan Rahmlow¹, Elizabeth A Shuster, Jacob Dominik, H Gordon Deen Jr, Dennis W Dickson, Allen J Aksamit Jr, Hector A Robles, William D Freeman

Affiliation

¹ Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.

PMID: 19001176
DOI: 10.1001/archneur.65.11.1538

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Arthritis, Rheumatoid / drug therapy
Biopsy
Brain / pathology
Cytarabine / administration & dosage
Cytarabine / therapeutic use
Humans
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / therapeutic use
Injections, Intravenous
Isoxazoles / adverse effects*
Isoxazoles / therapeutic use
Leflunomide
Leukoencephalopathy, Progressive Multifocal / chemically induced*
Leukoencephalopathy, Progressive Multifocal / complications
Leukoencephalopathy, Progressive Multifocal / diagnosis*
Leukoencephalopathy, Progressive Multifocal / drug therapy
Magnetic Resonance Imaging
Male
Middle Aged
Seizures / etiology
Staining and Labeling

Substances

Immunosuppressive Agents
Isoxazoles
Cytarabine
Leflunomide